StocksFin Logo
BeiGene, Ltd. country of incorporation
|
|
Mr. John V. Oyler
|
9,000 employees
NASDAQ | Healthcare | Biotechnology
Abiomed, Inc. country of incorporation
|
|
Mr. Michael Minogue
|
2,003 employees
NASDAQ | Healthcare | Medical Devices
Q322 reported Nov 9, 2022 Reporting Period
$387.63M 87.8% vs. Q321 Revenues Q322
-29.74% 68.2% vs. Q321 Gross Profit Margin
-143.84% ! 28.3% vs. Q321 Net Profit Margin
-690.56M ! -39.3% vs. Q321 Free Cash Flow Q322
$-5.33 ! -20.6% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q223
Q223 reported Nov 3, 2022 Reporting Period
$265.92M 7.2% vs. Q222 Revenues Q223
81.62% -0.8% vs. Q222 Gross Profit Margin
39.91% 73.9% vs. Q222 Net Profit Margin
7.81M -87.1% vs. Q222 Free Cash Flow Q223
$2.34 87.2% vs. Q222 EPS Q223
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q223
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Sep 30, 2022
Quick Ratio
3.74
6.82
Current Ratio
4.07
7.93
Cash Ratio
2.97
1.36
Price to Book
3
7.24
Price to Sales
35.99
41.92
Price to Earnings
-6.26
26.25